Agata Wiesiołek is a graduate of the Intercollegiate Faculty of Biotechnology of the University of Gdańsk, Poland.
She has been working in the area of clinical trials and with AstraZeneca since 2006. Agata’s current role is Senior Director, Study Management Late-Phase Development in Respiratory & Immunology area, supporting AstraZeneca clinical operations worldwide. Agata’s global experience includes strict project management in clinical trials & leading non-drug project initiatives leading to improvements and optimization ways of working in various Therapeutical Areas for different stages of trials.
Agata has been involved in managing and leading clinical research projects for more than 15 years and she also took a part of shaping and transforming AstraZeneca’s global Clinical Trials Site in Warsaw.